BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 8837677)

  • 1. Machining risk of beryllium disease and sensitization with median exposures below 2 micrograms/m3.
    Kreiss K; Mroz MM; Newman LS; Martyny J; Zhen B
    Am J Ind Med; 1996 Jul; 30(1):16-25. PubMed ID: 8837677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beryllium sensitization, chronic beryllium disease, and exposures at a beryllium mining and extraction facility.
    Deubner D; Kelsh M; Shum M; Maier L; Kent M; Lau E
    Appl Occup Environ Hyg; 2001 May; 16(5):579-92. PubMed ID: 11370937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure-response analysis for beryllium sensitization and chronic beryllium disease among workers in a beryllium metal machining plant.
    Madl AK; Unice K; Brown JL; Kolanz ME; Kent MS
    J Occup Environ Hyg; 2007 Jun; 4(6):448-66. PubMed ID: 17474035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant.
    Henneberger PK; Cumro D; Deubner DD; Kent MS; McCawley M; Kreiss K
    Int Arch Occup Environ Health; 2001 Apr; 74(3):167-76. PubMed ID: 11355290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Process-related risk of beryllium sensitization and disease in a copper-beryllium alloy facility.
    Schuler CR; Kent MS; Deubner DC; Berakis MT; McCawley M; Henneberger PK; Rossman MD; Kreiss K
    Am J Ind Med; 2005 Mar; 47(3):195-205. PubMed ID: 15712254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beryllium Exposure Control Program at the Cardiff Atomic Weapons Establishment in the United Kingdom.
    Johnson JS; Foote K; McClean M; Cogbill G
    Appl Occup Environ Hyg; 2001 May; 16(5):619-30. PubMed ID: 11370940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is total mass or mass of alveolar-deposited airborne particles of beryllium a better predictor of the prevalence of disease? A preliminary study of a beryllium processing facility.
    Kent MS; Robins TG; Madl AK
    Appl Occup Environ Hyg; 2001 May; 16(5):539-58. PubMed ID: 11370934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrafine beryllium number concentration as a possible metric for chronic beryllium disease risk.
    McCawley MA; Kent MS; Berakis MT
    Appl Occup Environ Hyg; 2001 May; 16(5):631-8. PubMed ID: 11370941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beryllium sensitization and chronic beryllium disease at a former nuclear weapons facility.
    Stange AW; Hilmas DE; Furman FJ; Gatliffe TR
    Appl Occup Environ Hyg; 2001 Mar; 16(3):405-17. PubMed ID: 11297055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitization and chronic beryllium disease among workers in copper-beryllium distribution centers.
    Stanton ML; Henneberger PK; Kent MS; Deubner DC; Kreiss K; Schuler CR
    J Occup Environ Med; 2006 Feb; 48(2):204-11. PubMed ID: 16474270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations.
    Kreiss K; Wasserman S; Mroz MM; Newman LS
    J Occup Med; 1993 Mar; 35(3):267-74. PubMed ID: 8455096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beryllium hypersensitivity and chronic beryllium lung disease.
    Santo Tomas LH
    Curr Opin Pulm Med; 2009 Mar; 15(2):165-9. PubMed ID: 19532033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Historical analysis of airborne beryllium concentrations at a copper beryllium machining facility (1964-2000).
    McAtee BL; Donovan EP; Gaffney SH; Frede W; Knutsen JS; Paustenbach DJ
    Ann Occup Hyg; 2009 Jun; 53(4):373-82. PubMed ID: 19383942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of an eight-hour occupational exposure limit for beryllium.
    Wambach PF; Tuggle RM
    Appl Occup Environ Hyg; 2000 Jul; 15(7):581-7. PubMed ID: 10893794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitization and chronic beryllium disease at a primary manufacturing facility, part 3: exposure-response among short-term workers.
    Schuler CR; Virji MA; Deubner DC; Stanton ML; Stefaniak AB; Day GA; Park JY; Kent MS; Sparks R; Kreiss K
    Scand J Work Environ Health; 2012 May; 38(3):270-81. PubMed ID: 21877099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure pathway assessment at a copper-beryllium alloy facility.
    Day GA; Dufresne A; Stefaniak AB; Schuler CR; Stanton ML; Miller WE; Kent MS; Deubner DC; Kreiss K; Hoover MD
    Ann Occup Hyg; 2007 Jan; 51(1):67-80. PubMed ID: 16844720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risks of beryllium disease related to work processes at a metal, alloy, and oxide production plant.
    Kreiss K; Mroz MM; Zhen B; Wiedemann H; Barna B
    Occup Environ Med; 1997 Aug; 54(8):605-12. PubMed ID: 9326165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic beryllium disease in a precious metal refinery. Clinical epidemiologic and immunologic evidence for continuing risk from exposure to low level beryllium fume.
    Cullen MR; Kominsky JR; Rossman MD; Cherniack MG; Rankin JA; Balmes JR; Kern JA; Daniele RP; Palmer L; Naegel GP
    Am Rev Respir Dis; 1987 Jan; 135(1):201-8. PubMed ID: 3492158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comments on the choice of exposure metrics as risk indicators.
    Wambach PF
    J Occup Environ Hyg; 2007 Oct; 4(10):D103-4; author reply D104-8. PubMed ID: 17763067
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison and critique of historical and current exposure assessment methods for beryllium: implications for evaluating risk of chronic beryllium disease.
    Kolanz ME; Madl AK; Kelsh MA; Kent MS; Kalmes RM; Paustenbach DJ
    Appl Occup Environ Hyg; 2001 May; 16(5):593-614. PubMed ID: 11370938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.